Table 1.
Characteristics of patients with TNBC (n = 88)
|
Characteristics |
TN-IBC |
TN-non IBC |
P
value |
||||
|---|---|---|---|---|---|---|---|
| No. of patients (%) | No. of patients (%) | ||||||
|
Total number of patients |
39 |
49 |
|
||||
|
Age (years), median (min-max) |
49 (26-78) |
56 (28-77) |
0.1681 |
||||
|
Clinical stage of diagnosis |
|
|
|
I |
9 |
(19) |
8.904e-09 |
| |
|
|
II |
17 |
(35) |
||
| III |
27 |
(69) |
III |
18 |
(36) |
||
| IV |
5 |
(13) |
IV |
5 |
(10) |
||
| Unknown |
7 |
(18) |
Unknown |
0 |
(0) |
||
|
Nuclear grade |
I |
0 |
(0) |
I |
3 |
(6) |
0.2048 |
| II |
4 |
(10) |
II |
10 |
(20) |
||
| III |
33 |
(85) |
III |
35 |
(72) |
||
| Unknown |
2 |
(5) |
Unknown |
1 |
(2) |
||
|
Tumor embolism |
Positive |
24 |
(62) |
Positive |
3 |
(6) |
3.604e-09 |
| Negative |
12 |
(30) |
Negative |
20 |
(41) |
||
| Unknown |
2 |
(8) |
Unknown |
26 |
(53) |
||
|
Neoadjuvant therapy (stages I-III) |
Positive |
21 |
(78) |
Positive |
29 |
(66) |
0.1684 |
| Negative |
5 |
(18) |
Negative |
15 |
(34) |
||
| Unknown | 1 | (4) | Unknown | 0 | (0) | ||